Dr. Jun J. Yang has a long-standing interest in human genetics, dating back to his early education in China where he received his undergrad and master’s degrees. He completed his PhD training at Purdue University and moved to St. Jude where he transitioned from postdoc training to faculty in 2010. Dr. Yang currently serves as Vice Chair for the Department of Pharmacy and Pharmaceutical Sciences and is the Associate Director of the Hematological Malignancies T32 Training Program at the St. Jude Comprehensive Cancer Center. He was elected President of the Pharmacogenomics Research Network in 2021. Dr. Yang has been continuously funded by the NIH since 2011 and receives funding from prestigious nonprofit organizations including the V Foundation. Dr. Yang is committed to genomic and pharmacogenomic research of pediatric leukemia and leverages multi-disciplinary collaborations to ask scientific questions on a global scale.